Cellect Bio

Cellect Biotechnology, Inc. has made a breakthrough in the stem cell field by developing a patented technology for screening and enriching stem cells — ApoGraft™. The core of this technology platform is the creation of a unique microenvironment that promotes apoptosis. In this culture microenvironment, mature cells undergo accelerated apoptosis, while stem cells are spared from apoptosis and reproduce more rapidly, thereby enabling the screening and enrichment of stem cells.